Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells

Japanese Journal of Cancer Research

Volumn 87, Issue 4, 1996, Pages 377-384

  Akagi, Morihisa ^a   Yasui, Wataru ^a   Akama, Yoshihiko ^a   Yokozaki, Hiroshi ^a   Tahara, Hidetoshi ^a   Haruma, Ken ^a   Kajiyama, Goro ^a   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell growth inhibition; Gastric carcinoma cells; p21; p53; TGF

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; MESSENGER RNA; PROTEIN P21; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CARCINOMA; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0029984594     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00233.x     Document Type: Article

References (49)

1. Moses, H. L., Yang, E. Y. and Pietenpol, J. A. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 63, 245-247 (1990).
2. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. and Massagué, J. Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation. Cell, 62, 175-185 (1990).
3. Sherr, C. J. Mammalian G1 cyclins. Cell, 73, 1059-1065 (1993).
4. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).
5. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M. and Massagué, J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science, 260, 536-539 (1993).
6. Ewen, M. E., Sluss, H. K., Whitehouse, L. L. and Livingston, D. M. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74, 1009-1020 (1993).
7. Satterwhite, D. J., Aakre, M. E., Gorska, A. E. and Moses, H. L. Inhibition of cell growth by TGFβ1 is associated with inhibition of B-myb and cyclin A in both Balb/MK and Mv1Lu cells. Cell Growth Differ., 5, 789-799 (1994).
8. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M. and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211, 90-98 (1994).
9. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell, 75, 805-816 (1993).
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
11. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22 (1994).
12. Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74 (1994).
13. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66 (1994).
14. Serrano, M., Hannon, G. J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature, 366, 704-707 (1993).
15. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature, 371, 257-261 (1994).
16. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J. and Reed, S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023 (1994).
17. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54, 3391-3395 (1994).
18. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B. and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55, 668-674 (1995).
19. Yokozaki, H., Kuniyasu H., Kitadai, Y., Nishimura, K., Todo, H., Ayhan, A., Yasui, W., Ito, H. and Tahara, E. p53 point mutations in primary human gastric carcinomas. J. Cancer Res. Clin. Oncol., 119, 67-70 (1992).
20. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T. and Tahara, E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res., 86, 617-621 (1995).
21. cdc2 and its kinase activity in human gastric and colonic carcinomas. Int. J. Cancer, 53, 36-41 (1993).
22. Ito, M., Yasui, W., Nakayama, H., Yokozaki, H., Ito, H. and Tahara, E. Reduced levels of transforming growth factor-β type I receptor in human gastric carcinomas. Jpn. J. Cancer Res., 83, 86-92 (1992).
23. Yoshida, K., Yokozaki, H., Niimoto, M., Ito, H., Ito, M. and Tahara, E. Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int. J. Cancer, 44, 394-398 (1989).
24. Ochiai, A., Yasui, W. and Tahara, E. Growth-promoting effect of gastrin in human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res., 76, 1064-1071 (1985).
25. Hojo, H. Establishment of culture cell lines of human stomach cancer: origin and their morphological characteristics. Niigata Med. J., 91, 737-752 (1977) (in Japanese).
26. Ito, M., Yasui, W., Kyo, E., Yokozaki, H., Nakayama, H., Ito, H. and Tahara, E. Growth inhibition of transforming growth factor β on human gastric carcinoma cells: receptor and postreceptor signaling. Cancer Res., 52, 295-300 (1992).
27. Mattar, R., Yokozaki, H., Yasui, W., Ito, H. and Tahara, E. p53 gene mutation in gastric cancer cell lines. Life Sci. Adv. Oncol., 11, 7-12 (1992).
28. Baker, S. J., Markowitz, S., Fearon, E. R., Wilson, J. K. V. and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915 (1990).
29. Maniatis, T., Fritsch, E. F. and Sambrook, J. "Molecular Cloning: A Laboratory Manual," pp. 187-210 (1984). Cold Spring Harbor Laboratory, New York.
30. Yoshida, K., Kyo, E., Tsujino, T., Sano, T., Niimoto, M. and Tahara, E. Expression of epidermal growth factor, transforming growth factor-α and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn. J. Cancer Res., 81, 43-51 (1990).
31. Harlow, E., Williamson, N. M., Ralston, R., Helfman, D. M. and Adams, T. E. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell. Biol., 5, 1601-1610 (1985).
32. Yasui, W., Sano, T., Nishimura, K., Kitadai, Y., Ji, Z.-Q., Yokozaki, H., Ito, H. and Tahara, E. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int. J. Cancer, 54, 49-52 (1993).
33. Finlay, C. A., Hinds, P. W. and Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093 (1989).
34. Schöler, H. R., Balling, R., Hatzopoulos, A. K., Suzuki, N. and Gruss, P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J., 8, 2551-2557 (1989).
35. Alexandrow, M. G. and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55, 1452-1457 (1995).
36. Ko, T. C., Sheng, H. M., Reisman, D., Thompson, E. A. and Beauchamp, R. D. Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene, 10, 177-184 (1995).
37. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L.-Z., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
38. Myeroff, L., Parsons, R., Kim, S.-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y.-J., Lee, H. Y., Park, J.-G., Lynch, H. T., Roberts, A. B., Vogelstein, B. and Markowitz, S. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55, 5545-5547 (1995).
39. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science, 252, 1708-1711 (1991).
40. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R. and Prives, C. Wild-type p53 activates transcription in vitro. Nature, 358, 83-86 (1992).
41. Zhang, W., Funk, W. D., Wright, W. E., Shay, J. W. and Deisseroth, A. B. Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene, 8, 2555-2559 (1993).
42. Chen, J.-Y., Funk, W. D., Wright, W. E., Shay, J. W. and Minna, J. D. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene, 8, 2159-2166 (1993).
43. Greenblatt, M. S., Bennett, W. P., Hollstein, M. and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-1878 (1994).
44. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y. and Wang, X.-F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA, 92, 5545-5549 (1995).
45. Geng, Y. and Weinberg, R. A. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA, 90, 10315-10319 (1993).
46. Barlat, I., Fesquet, D., Brechot, C., Henglein, B., Dupuy d'Angeac, A., Vie, A. and Blanchard, J. M. Loss of the G1-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblasts. Cell Growth Differ., 4, 105-113 (1993).
47. Barlat, I., Henglein, B., Plet, A., Lamb, N., Fernandez, A., McKenzie, F., Pouysségur, J., Vié, A. and Blanchard, J. M. TGF-β1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. Oncogene, 11, 1309-1318 (1995).
48. Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R. C., Jr., Iglehart, J. D. and Marks, J. R. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ., 5, 1301-1307 (1994).
49. Li, C.-Y., Suardet, L. and Little, J. B. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem., 270, 4971-4974 (1995).